Net Income per Share |
Net Income per Share Basic net income per share is calculated by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share adjusts basic net income per share for all the potentially dilutive shares outstanding during the period. When the Company’s convertible notes are dilutive, interest on the convertible notes, net of tax, is added back to net income in order to calculate diluted earnings available to common shareholders.
The following table sets forth the computation of basic and diluted net income per common share: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | | June 27, 2025 | | June 28, 2024 | | June 27, 2025 | | June 28, 2024 | Net income per share: | | | | | | | | Basic | $ | 0.55 | | | $ | 0.41 | | | $ | 0.81 | | | $ | 0.46 | | Diluted | $ | 0.49 | | | $ | 0.37 | | | $ | 0.74 | | | $ | 0.44 | | Weighted average common shares: | | | | | | | | Basic | 38,883,019 | | | 37,924,931 | | | 38,788,843 | | | 37,871,080 | | Diluted | 46,031,127 | | | 45,947,728 | | | 46,055,696 | | | 45,959,061 | |
Reconciliation of net income per common share: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | | June 27, 2025 | | June 28, 2024 | | June 27, 2025 | | June 28, 2024 | Numerator: | | | | | | | | Net income | $ | 21,241 | | | $ | 15,524 | | | $ | 31,529 | | | $ | 17,455 | | Add effect of dilutive securities | | | | | | | | Interest on convertible notes, net of tax | 1,226 | | | 1,322 | | | 2,451 | | | 2,628 | | Net income available to common shareholders | $ | 22,467 | | | $ | 16,846 | | | $ | 33,980 | | | $ | 20,083 | | Denominator: | | | | | | | | Weighted average basic common shares outstanding | 38,883,019 | | | 37,924,931 | | | 38,788,843 | | | 37,871,080 | | Dilutive effect of unvested common shares | 581,013 | | | 573,930 | | | 700,950 | | | 642,767 | | Dilutive effect of stock options and warrants | 72,125 | | | 56,050 | | | 70,933 | | | 52,397 | | Dilutive effect of convertible notes | 6,494,970 | | | 7,392,817 | | | 6,494,970 | | | 7,392,817 | | Weighted average diluted common shares outstanding | 46,031,127 | | | 45,947,728 | | | 46,055,696 | | | 45,959,061 | |
Potentially dilutive securities that have been excluded from the calculation of diluted net income per common share because the effect is anti-dilutive are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | | June 27, 2025 | | June 28, 2024 | | June 27, 2025 | | June 28, 2024 | Restricted share awards (“RSAs”) and restricted stock units (“RSUs”) | 215,454 | | | 160,273 | | | 259,505 | | | 286,769 | | | | | | | | | | | | | | | | | |
|